Drugs@FDA: FDA-Approved Drugs

Home | Previous Page

Abbreviated New Drug Application (ANDA): 202148
Company: MYLAN

Products on ANDA 202148

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	TE Code	RLD	RS
ACITRETIN	ACITRETIN	10MG	CAPSULE;ORAL	Prescription	AB	No	No
ACITRETIN	ACITRETIN	25MG	CAPSULE;ORAL	Prescription	AB	No	No

Approval Date(s) and History, Letters, Labels, Reviews for ANDA 202148

Original Approvals or Tentative Approvals

Action Date	Submission	Action Type	Submission Classification	Review Priority; Orphan Status	Letters, Reviews, Labels, Patient Package Insert	Notes	Url
09/10/2015	ORIG-1	Approval			Letter (PDF)	Label is not available on this site.	https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2015/202148Orig1s000ltr.pdf

Supplements

Action Date	Submission	Supplement Categories or Approval Type	Letters, Reviews, Labels, Patient Package Insert	Note	Url
06/25/2020	SUPPL-3	Labeling-Package Insert, Labeling-Medication Guide		Label is not available on this site.

Therapeutic Equivalents for ANDA 202148

ACITRETIN

CAPSULE;ORAL; 10MG
TE Code = AB

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	RLD	TE Code	Application No.	Company
ACITRETIN	ACITRETIN	10MG	CAPSULE;ORAL	Prescription	No	AB	091455	BARR LABS INC
ACITRETIN	ACITRETIN	10MG	CAPSULE;ORAL	Prescription	No	AB	202552	IMPAX LABS INC
ACITRETIN	ACITRETIN	10MG	CAPSULE;ORAL	Prescription	No	AB	202148	MYLAN
ACITRETIN	ACITRETIN	10MG	CAPSULE;ORAL	Prescription	No	AB	204633	SIGMAPHARM LABS LLC

CAPSULE;ORAL; 25MG
TE Code = AB

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	RLD	TE Code	Application No.	Company
ACITRETIN	ACITRETIN	25MG	CAPSULE;ORAL	Prescription	No	AB	091455	BARR LABS INC
ACITRETIN	ACITRETIN	25MG	CAPSULE;ORAL	Prescription	No	AB	202552	IMPAX LABS INC
ACITRETIN	ACITRETIN	25MG	CAPSULE;ORAL	Prescription	No	AB	202148	MYLAN
ACITRETIN	ACITRETIN	25MG	CAPSULE;ORAL	Prescription	No	AB	204633	SIGMAPHARM LABS LLC